Clinical trial

Phase 1 Study of PF-08046033 in Advanced Solid Tumors

NCT07519655

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-04-08

PhasePHASE1

Study timeline

Study start (actual)2026-04-08Date precision: day

Registry last updated2026-10-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-Small-Cell Lungunresolved

Esophageal Cancerunresolved

Cutaneous Melanomaunresolved

Interventions

PF-08046033DRUG

Sponsors & collaborators

Pfizerlead sponsor

Mapped research locations

New HavenConnecticut, United States4 NashvilleTennessee, United States2 DenverColorado, United States2 FairfaxVirginia, United States2 MadridSpain1 ToulouseFrance1 VillejuifFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07519655 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.